MALVERN, PA – February 9, 2026 – YPrime, today announced it has earned an EcoVadis silver medal, placing the company in the top 15% of organizations globally for environmental, social, and governance (ESG) performance. The recognition positions YPrime among leading ESG-focused clinical trial technology providers and reflects continued progress across sustainability, ethical governance, and responsible innovation.
EcoVadis evaluates more than 150,000 companies worldwide on ESG criteria that are increasingly used by sponsors and CROs to assess long-term clinical trial technology partners. YPrime’s silver medal reflects an 18% year-over-year improvement and a 109% increase since 2024, demonstrating sustained advancement across its ESG framework.
Why ESG Leadership Matters in Clinical Trial Technology
As ESG considerations play a growing role in sponsor and CRO vendor selection, independent validation has become a critical trust signal. YPrime’s EcoVadis silver medal provides third-party confirmation that the company operates with strong environmental stewardship, ethical business practices, and governance aligned to global clinical research expectations.
“At YPrime, ESG is not a parallel initiative, it’s embedded in how we build, deliver, and support clinical trial technology at scale,” said Ian Lennox, Chief Executive Officer of YPrime. “Earning a silver medal from EcoVadis validates the investments we’ve made to operate responsibly at global scale while continuing to help sponsors and CROs run faster trials, with certainty. As expectations around sustainability and vendor accountability continue to rise, we’re committed to raising the bar alongside our customers.”
“ESG performance has become a meaningful signal of how well a company operates, not just socially, but operationally and ethically,” said Otis Johnson, PhD, sustainability and ESG advisor to the life sciences industry. “YPrime’s progress reflects a disciplined, measurable approach to environmental stewardship, ethical governance, and workforce responsibility. That kind of maturity matters to sponsors who are evaluating long-term partners for global clinical trials.”
Environmental Sustainability Through Digital Clinical Trials
YPrime recently received the Clinical Trials Arena Environmental Excellence Award for embedding sustainability directly into clinical trial execution. The company’s digital-first platforms—including eCOA, IRT, and eConsent—replace paper-based processes, reduce site-dependent workflows, and help minimize shipments and travel. Over multiple years, these product and operational decisions have delivered measurable environmental impact:
- 87% reduction in printed trial documents over three years
- 100% reuse or recycling of clinical trial devices through circularity programs
- Zero Scope 1 emissions achieved, with reductions across Scope 2 and 3
- Sustainability integrated into supplier oversight, including a Supplier Code of Conduct
These outcomes reflect YPrime’s broader commitment to building responsible, future-ready clinical trial technology. The recognition follows recent advancements across the platform, including Advanced eCOA Oversight, Automated Data Change Forms (DCF), connected device integrations, and AI-supported eCOA localization. YPrime has also been named a Leader in the Everest Group 2025 eCOA PEAK Matrix® Assessment and recognized as a Trailblazer in Patient Engagement.
To learn more about YPrime’s sustainability efforts, award-winning innovations, and global clinical technology solutions, visit www.yprime.com.
About YPrime
YPrime simplifies clinical trials with eCOA, IRT, and eConsent solutions that combine speed, flexibility, and quality. The YPrime eCOA platform enhances participant compliance with an intuitive app and easy-to-use design, streamlines site workflows through a powerful eCOA portal, integrates seamlessly with connected devices, and supports sponsors with dashboards for better decision-making. AI-supported eCOA localization accelerates globalization, while pre-validated and configurable eCOA and IRT deliver faster study startup with quality metrics above industry standards. Trusted by top pharma leaders and emerging biotech companies alike, YPrime blends deep industry expertise and innovation to deliver reliable solutions. With nearly two decades of proven success, solutions in 250+ languages, and support in 100+ countries, YPrime is your partner to solve clinical research challenges with certainty. Visit www.yprime.com or email marketing@yprime.com.
Media Contact
Grazia Mohren
Senior Vice President, Marketing, YPrime
marketing@yprime.com